Abstract
Background
Intradialytic hypotension, a complication of intermittent hemodialysis, decreases the efficacy of dialysis and increases long-term mortality. This study was aimed to determine whether different predialysis ultrasound cardiopulmonary profiles could predict intradialytic hypotension.
Methods
This prospective observational single-center study was performed in 248 critically ill patients with acute kidney injury undergoing intermittent hemodialysis. Immediately before hemodialysis, vena cava collapsibility was measured by vena cava ultrasound and pulmonary congestion by lung ultrasound. Factors predicting intradialytic hypotension were identified by multiple logistic regression analysis.
Results
Intradialytic hypotension was observed in 31.9% (n = 79) of the patients, interruption of dialysis because of intradialytic hypotension occurred in 6.8% (n = 31) of the sessions, and overall 28-day mortality was 20.1% (n = 50). Patients were classified in four ultrasound profiles: (A) 108 with B lines > 14 and vena cava collapsibility > 11.5 mm m−2, (B) 38 with B lines < 14 and vena cava collapsibility ≤ 11.5 mm m−2, (C) 36 with B lines > 14 and vena cava collapsibility Di ≤ 11.5 mm m−2, and (D) 66 with B lines < 14 and vena cava collapsibility > 11.5 mm m−2. There was an increased risk of intradialytic hypotension in patients receiving norepinephrine (odds ratios = 15, p = 0.001) and with profiles B (odds ratios = 12, p = 0.001) and C (odds ratios = 17, p = 0.001).
Conclusion
In critically ill patients on intermittent hemodialysis, the absence of hypervolemia as assessed by lung and vena cava ultrasound predisposes to intradialytic hypotension and suggests alternative techniques of hemodialysis to provide better hemodynamic stability.
Keywords: Ultrasound, Dialysis, Hypotension, Acute kidney injury, Critically ill patients, Profiles
Introduction
Ultrafiltration-induced fluid removal for fluid balance control is a major target of renal replacement therapy [1]. However, in critically ill patients, intradialytic hypotension (IDH) is a frequent complication of intermittent hemodialysis and it may decrease the efficacy of renal replacement therapy [2, 3].
The ultrafiltration rate is set to ensure fluid removal required to reduce fluid overload. However, assessment of fluid overload in critically ill patients may be a challenge, because pulmonary congestion is poorly correlated with clinical signs [4]. One alternative approach is the utilization of transthoracic lung ultrasound. A score based on the number of B lines accurately measures the degree of lung congestion and may guide ultrafiltration rate [4–6]. In addition, the rate of disappearance of B lines during intermittent hemodialysis shows a good correlation with the volume of ultrafiltration and dry weight [7, 8].
The pathogenesis of IDH includes the dialysis process itself and critically ill patient-related factors. It has been postulated that the ultrafiltration rate may lead to a reduction in preload, predisposing to hemodynamic instability. Moreover, the dialysis process may interfere with compensatory mechanisms, predisposing to an increased risk of hypotension [9]. As such, it is not clear whether IDH is directly related to preload dependence or to other factors. Clinical studies have been controversial. One study has reported that a positive passive leg raising test before starting dialysis predicts IDH during renal replacement therapy [10]. Another has shown that, in critically ill patients, the majority of hypotensive episodes occurring during intermittent hemodialysis are unrelated to preload dependence and likely related to vasomotor tone alterations [11]. Furthermore, clinical and radiological tools for assessing volume status are subjected to a wide variability of interpretation [12, 13]. As an alternative, the ultrasound measurement of inferior vena cava diameter has been reported to be an accurate method for the assessment of fluid status in critically ill patients [14] and in patients undergoing hemodialysis [15–17].
Although several studies have confirmed the emergent role of biomarkers such as natriuretic peptides [18], copeptin, and bioimpedance vector analysis (BIVA) in the management of volume overload, bedside lung ultrasound appears a sensitive tool for evaluating changes in extravascular lung water in dialysis patients [18, 19]. The primary aim of the present study is to determine whether different predialytic cardiopulmonary profiles, defined on sonographic findings, could predict IDH in critically ill patients undergoing intermittent hemodialysis. The secondary aim was to identify risk factors for IDH in this population.
Methods
Study design
This was a prospective observational single-center study performed between January 1, 2015, and April 30, 2018, in a 30-bed medical intensive care unit (ICU), at Hospital Português, a tertiary hospital in Salvador, Brazil. The study was approved by the Ethical Committee from Centro de Estudos Egaz Muniz (CAAE: 89428318.000005029). Written informed consent was waived for this observational and non-interventional study. Critically ill patients were included in the study if they fulfilled the following criteria: (i) age > 18 years, (ii) acute kidney injury (AKI) defined by KDIGO 3, and (iii) treatment by intermittent hemodialysis. Patients with right ventricle dysfunction, valvar heart disease, lung hyperinflation, increased abdominal pressure, marked inferior vena cava respiratory translational motion, and the use of compression stockings and patients with inadequate transthoracic window were excluded from the study.
Intermittent hemodialysis sessions
The nephrology team in charge of patient care was responsible for the timing of initiation of dialysis and prescription. Intermittent hemodialysis sessions were performed on the basis of standard clinical guidelines, including AKI with hemodynamic stability, ongoing hypercatabolism, hyperkalemia, severe acidosis, presumed volume overload, and respiratory distress. The indication for intermittent hemodialysis refers to patients without vasopressors or in low dose of vasopressors (norepinephrine dose ≤ 0.3 mg kg−1 min−1) for at least 6 h before initiation of dialysis with mean arterial pressure (MAP) ≥ 65 mmHg. For each patient, clinical, laboratory, and hemodynamic variables were used to inform clinical decision-making of ultrafiltration rate. Intermittent hemodialysis was performed with Fresenius 4008 S (Gambro Hospal, Meyzieu, France), and dialysate concentrate solutions with 1.75 mmol/L calcium concentration. Intradialytic hypotension (IDH) was defined as the occurrence of a MAP below 65 mmHg during the dialysis session [11].
Ultrasound procedures and classifications
Vena cava collapsibility measurement and B line determination were performed by physicians with expertise in cardiac and lung ultrasound for critically ill patients [7, 20–22] (see Additional file 5).
Statistical analysis
Statistical analysis was performed using SPSS version 19.0 for Windows (SPSS Inc., Chicago, IL). Data were tested for normality by visual inspection and the use of Kolmogorov-Smirnov test. Continuous variables were expressed as median (interquartile range, IQR) and were compared by a nonparametric Mann-Whitney test. Results are expressed as mean ± SD or median (IQR). Proportions were compared by the χ2 test. Variables were compared between groups of sessions (with hypotension vs without hypotension). The binary classification (“no intradialytic hypotension” vs “intradialytic hypotension”) was used as an outcome variable in a way that “no hypotension” and “hypotension” were coded as 0 and 1, respectively. Quantitative and qualitative variables associated with hypotension with a p value below 0.05 in univariate analysis were selected for inclusion in a multivariable logistic regression model. Logistic regression with both categorical and continuous independent variables was used to build predictive models for the occurrence of hypotension. A one way-ANOVA was used for comparison between groups of patients according to ultrasound profiles. The four “ultrasound profiles” were compared for association with hypotension, dialysis discontinuation, or mortality in 28 days, using χ2 analysis. Statistical significance was assumed at the 5% level.
Results
From January 2016 to March 2018, 248 AKI patients requiring intermittent hemodialysis were considered eligible. Median age was 68, and the age range was 58–76; 149 (60.1%) patients were male; the median Charlson score was 10 (8–12); the median APACHE II score was 15 (12–18); and SOFA score was 8 (6–10).
Intradialytic hypotension: incidence and predictive factors
Patients’ characteristics are shown in Table 1 and hemodialysis sessions’ characteristics in Table 2. IDH was observed in 31.9% (n = 79) of the patients, interruption of dialysis because of IDH occurred in 6.8% (n = 31) of the sessions, and overall 28-day mortality was 20.1%. The presence of sepsis, the use of norepinephrine, a low predialysis MAP, a high predialysis lactate level, the use of mechanical ventilation, and elderly age were factors significantly associated with IDH (Table 1). There was a difference in median ultrafiltration volume (Table 1) between patients with and without IDH: 893 ml (0–1500) in patients with IDH vs 1242 ml (675–2000) in patients without IDH (p = 0.020).
Table 1.
Clinical, ultrasound, and biological characteristics of patients
| All patients | Intradialytic hypotension | p | ||
|---|---|---|---|---|
| No | Yes | |||
| N = 248 | 169 (68.1%) | 79 (31.9%) | ||
| Clinical characteristics | ||||
| Gender | 0.684 | |||
| - Male, n (%) | 149 (60.1%) | 103 (60.9%) | 46 (58.2%) | |
| - Female, n (%) | 99 (39.9%) | 66 (39.1%) | 33 (41.8%) | |
| Age (years) | 68.0 (58.2–76) | 66 (55–76) | 70 (64–76) | 0.018 |
| Charlson score | 10 (8–12) | 10 (8–12) | 10 (8–12) | 0.116 |
| APACHE II | 15 (12–18) | 14 (12–18) | 16 (13–18) | 0.215 |
| SOFA | 8 (6–100) | 8 (6–10) | 8 (7–10) | 0.057 |
| Sepsis, n (%) | 123 (49.6%) | 71 (42%) | 52 (65.8%) | < 0.001 |
| Use of norepinephrine, n (%) | 37 (14.9%) | 5 (3%) | 32 (40.5%) | < 0.001 |
| Mechanical ventilation, n (%) | 34 (13.7%) | 14 (8.3%) | 20 (25.3%) | < 0.001 |
| Predialytic arterial pressure | ||||
| Systolic blood pressure, mmHg | 132 (114.2–152) | 140 (123–160) | 114 (103–135) | < 0.001 |
| Diastolic blood pressure, mmHg | 70 (60.2–80.7) | 71 (64–86) | 64 (58–73) | < 0.001 |
| Mean blood pressure, mmHg | 89.5 (79.0–105.0) | 94 (84–109) | 81 (75–90) | < 0.001 |
| Biological characteristics | ||||
| Hemoglobin, g/dL | 9 (7.6–10.1) | 9 (7.4–10.1) | 9 (7.8–10.2) | 0.839 |
| Bicarbonate, mEq/L | 20(18–23) | 20 (18–23) | 20 (16–22) | 0.321 |
| Sodium, mEq/L | 138 (138–140) | 138 (135–141) | 139 (134–141) | 0.565 |
| Urea, mg/dL | 143 (114.2–194) | 143 (110–195) | 142 (119–194) | 0.659 |
| Lactate, mmol/L | 1.4 (1.1–1.9) | 1.3 (1.1–1.7) | 1.7 (1.2–2.2) | < 0.001 |
| Fluid balance, mL | 1772 (1540–2320) | 1800 (1535–2320) | 1750 (1540–2350) | 0.762 |
| Ultrasound characteristics | ||||
| Pulmonary congestion, n (%) | 144 (58.1%) | 106 (62.7%) | 38 (48.1%) | 0.030 |
| IVC collapsibility, n (%) | 74 (29.8%) | 14 (8.3%) | 60 (75.9%) | < 0.001 |
APACHE Acute Physiology, Age, Chronic Health Evaluation; SOFA Sequential Organ Failure Assessment score; IVC inferior vena cava; IQR interquartile. Data are expressed as number (percentage) for categorical variables or median (1st quartile–3rd quartile) for continuous variables
Table 2.
Dialysis sessions’ characteristics
| Dialysis characteristics | All patients | Intradialytic hypotension | p | |
|---|---|---|---|---|
| No | Yes | |||
| N = 248 | 169 (68.1%) | 79 (31.9%) | ||
| Duration, min | 240 (180–240) | 240 (180–240) | 210 (150–240) | 0.140 |
| Ultrafiltration, mL | 1000 (200–2000) | 1.242.01 | 893.03 | 0.020 |
| Blood flow, mL/min | 300 (250–300) | 0.010 | ||
| - 200 | 24 (14.2%) | 24 (30.4%) | ||
| - 250 | 47 (27.8%) | 16 (20.3%) | ||
| - 300 | 98 (58%) | 38 (48.1%) | ||
| - 350 | 0 (0%) | 1 (1.3%) | ||
| Dialysate flow, mL/min | 500 (500–500) | 0.002 | ||
| - 300 | 12 (7.1%) | 17 (21.5%) | ||
| - 320 | 0 (0%) | 1 (1.3%) | ||
| - 500 | 157 (92.9%) | 61 (77.2%) | ||
| Temperature, °C | 36 (36–36) | 36.0 (35.5–36.5) | 36.0 (35.5–36.5) | 0.416 |
| Sodium, mEq/L | 138 (138–140) | 138 (138–140) | 138 (135–141) | |
Data are expressed as number (percentage) for categorical variables or median (1st quartile–3rd quartile) for continuous variables
Regarding ultrasound findings, pulmonary congestion (as defined by a B line score ≥ 14) was found in 38 (48.1%) patients with IDH and 106 (62.7%) patients without IDH (p = 0.030). Inferior vena cava collapsibility (as defined by a VCDi ≤ 11.5 mm m2) was found in 60 (75.9%) patients with IDH and 14 (8.3%) patients without IDH (p < 0.001).
The predictive multiple logistic regression model of IDH demonstrated that MAP, use of norepinephrine, and inferior vena cava collapsibility were associated with the occurrence of IDH (Table 3). Specifically, pulmonary congestion (a B line score ≥ 14) and higher MAP appeared protective against IDH (Table 3).
Table 3.
Multivariate logistic regression analysis for the occurrence of intradialytic hypotension
| Variable | Parameter estimated | Standard error | Odds ratio | 95% CI | p |
|---|---|---|---|---|---|
| Age | 0.018 | 0.015 | 1.018 | 0.989–1.049 | 0.228 |
| Blood flow rate | 0.006 | 0.007 | 1.006 | 0.993–1.019 | 0.379 |
| Dialysate flow rate | − 0.007 | 0.004 | 0.993 | 0.984–1.001 | 0.096 |
| Ultrafiltration | 0.001 | 0.004 | 1.000 | 1.000–1.001 | 0.136 |
| Mean blood pressure | − 0.039 | 0.015 | 0.962 | 0.934–0.991 | 0.010 |
| Lactate | − 0.187 | 0.398 | 0.829 | 0.380–1.810 | 0.638 |
| Use of norepinephrine | 2.736 | 0.679 | 15.425 | 4.078–58.353 | 0.001 |
| Pulmonary congestion | − 1.025 | 0.462 | 0.448 | 0.106–0.888 | 0.027 |
| Inferior vena cava collapsibility | 3.573 | 0.487 | 35.635 | 13.722–92.538 | 0.001 |
| Mechanical ventilation | − 0.803 | 0.737 | 0.359 | 0.106–1.900 | 0.276 |
| Sepsis | 0.584 | 0.466 | 1.793 | 0.719–4.470 | 0.210 |
| Constant | 1.825 |
Ultrasound profiles
Based on lung ultrasound and VCDi, we could classify patients in four distinct profiles (Fig. 1) (Additional files 1, 2, 3, and 4): (A) 108 patients had pulmonary congestion and hypervolemia, (B) 38 patients did not have pulmonary congestion nor hypervolemia, (C) 36 patients had pulmonary congestion without hypervolemia, and (D) 66 patients had hypervolemia without pulmonary congestion. Baseline characteristics of the patients in the four ultrasound profiles are listed in Table 4. The presence of IDH was different between profiles (p < 0.001). All other variables but age were similar between the four different profiles.
Fig. 1.
Vena cava and lung ultrasound profiles. (Profile A) 66-year-old patient admitted to the intensive care unit for community-acquired pneumonia with acute kidney injury KDIGO 3 requiring hemodialysis. The patient had a positive fluid balance of 6.5 L and did not receive vasoactive support. In the right upper anterior thoracic region, multiple coalescent B lines issued from justapleural consolidations typical of bronchopneumonia are visible. As shown in the corresponding video file (Additional files 1, 2, 3, and 4), lung sliding is nearly abolished caused by inflammation/infection of pleural layers. The vena cava appears well filled and does not show any significant collapsibility with respiratory movements. (Profile B) 28-year-old patient admitted to the intensive care unit for a urinary tract infection, and acute kidney injury KDIGO 3 requiring dialysis was diagnosed. The patient had a positive fluid balance of 2.5 L, and he was on vasoactive support. In the right upper anterior thoracic region, predominant A lines are visible. As shown in the corresponding video file (Additional files 1, 2, 3, and 4), lung sliding is normal. The vena cava appears filled and shows not significant collapsibility with respiratory movements. (Profile C) 53-year-old patient admitted to the intensive care unit for an alcoholic acute pancreatitis. AKI (KDIGO) 2 was diagnosed, and intermittent dialysis was initiated. The patient had a positive fluid balance of 8.5 L, and he was on vasoactive support. In the right upper anterior thoracic region, white lines from the pleural line to the bottom (B–lines–comets) are visible. As shown in the corresponding video file (Additional files 1, 2, 3 and 4), lung sliding is normal. The vena cava appears collapsed with respiratory movements. (Profile D) 73-year-old patient admitted to the intensive care unit for an acute mesenteric ischemia treated by an extended right hemicolectomy. The patient developed AKI KDIGO 3, and intermittent dialysis was started. The patient had a positive fluid balance of 5.5 L and did not receive vasoactive support. In the right upper anterior thoracic region, horizontal lines (A lines) are visible. As shown in the corresponding video file (Additional files 1, 2, 3, and 4), lung sliding is normal. The vena cava appears collapsed with respiratory movements
Table 4.
Baseline characteristics of patients according to the ultrasound profile
| Profile | A, n = 108 | B, n = 38 | C, n = 36 | D, n = 66 | p |
|---|---|---|---|---|---|
| Hypotension, n (%) | 8 (7.4%) | 30 (78.9%) | 30 (83.3%) | 11 (16.7%) | 0.001 |
| Gender | 0.346 | ||||
| Male, n (%) | 67 (62%) | 26 (68.4%) | 22 (14.8%) | 34 (51.4%) | |
| Female, n (%) | 41 (41.4%) | 12 (31.6%) | 14 (38.9%) | 32 (48.5%) | |
| Age (years) | 65.0 ± 15.2 | 69.9 ± 11.8 | 66.0 ± 12.4 | 66.0 ± 18.1 | 0.016 |
| Charlson score | 10.3 ± 2.7 | 10.6 ± 2.8 | 10.7 ± 2.6 | 10.0 ± 2.8 | 0.113 |
| APACHE II | 15.2 ± 3.7 | 15.6 ± 4.3 | 15.9 ± 3.3 | 15.4 ± 5.6 | 0.470 |
| SOFA | 8.2 ± 2.3 | 8.4 ± 2.6 | 9.2 ± 2.6 | 8.4 ± 2.7 | 0.677 |
| Sepsis, n (%) | 59 (54.6%) | 17 (44.7%) | 15 (41.7%) | 32 (48.5%) | 0.495 |
| Use of norepinephrine, n (%) | 19 (17.6%) | 6 (15.8%) | 4 (11.1%) | 8 (12.1%) | 0.694 |
| Mechanical ventilation, n (%) | 16 (14.8%) | 8 (21.1%) | 3 (8.3%) | 7 (10.6%) | 0.353 |
| Fluid balance (milliliters) | 1952.2 ± 702.0 | 1953.0 ± 673.5 | 1899.8 ± 667.5 | 1951.8 ± 592.9 | 0.469 |
| Mortality 28 days, n (%) | 19 (17.6%) | 6 (15.8%) | 5 (13.9%) | 20 (30.3%) | 0.112 |
| Dialysis data | |||||
| Duration, min | 212.4 ± 47.5 | 202.6 ± 53.1 | 195.14 ± 81.1 | 212.7 ± 40.7 | 0.958 |
| Ultrafiltration, mL/min | 1197.2 ± 836.6 | 1072.4 ± 923.3 | 813.9 ± 818 | 1228.8 ± 40.7 | 0.428 |
| Blood flow rate, mL/min | 273.15 ± 35.80 | 248.7 ± 48.6 | 262.5 ± 42.0 | 274.24 ± 35.3 | 0.420 |
| Dialysate flow rate, mL/min | 485.18 ± 56.62 | 447.9 ± 88.4 | 455.5 ± 84.3 | 487.9 ± 48.1 | 0.628 |
| Sodium, mEq/L | 138.66 ± 1.28 | 138.6 ± 0.9 | 138.8 ± 1.5 | 138.8 ± 1.9 | 0.841 |
| Systemic data | |||||
| Temperature | 36.06 ± 0.25 | 36.0 ± 0.3 | 36.0 ± 0.3 | 36.0 ± 26.1 | 0.326 |
| Systolic blood pressure, mmHg | 139.1 ± 28.5 | 126.0 ± 0.3 | 123.0 ± 22.5 | 144.4 ± 26.1 | 0.855 |
| Diastolic blood pressure, mmHg | 72.8 ± 15.8 | 68.6 ± 16.9 | 67.2 ± 12.7 | 73.9 ± 16.8 | 0.831 |
| Mean blood pressure, mmHg | 94.9 ± 18.4 | 87.8 ± 18.3 | 85.8 ± 13.6 | 97.4 ± 17.5 | 0.793 |
| Blood test data | |||||
| Hemoglobin, /dL | 9.1 ± 2.2 | 9.2 ± 2.2 | 8.6 ± 2.2 | 8.6 ± 2.2 | 0.262 |
| Bicarbonate, mEq/L | 19.7 ± 3.8 | 18.8 ± 3.8 | 20.1 ± 5.2 | 20.1 ± 5.2 | 0.767 |
| Sodium, mEq/L | 138.2 ± 4.5 | 138.9 ± 8.5 | 137.4 ± 5.4 | 137.0 ± 6.6 | 0.396 |
| Urea, mg/dL | 157.6 ± 59.3 | 159.9 ± 50.3 | 157.5 ± 47.8 | 150.1 ± 61.7 | 0.802 |
| Lactate, mmol/L | 1.5 ± 0.6 | 1.8 ± 0.85 | 2.0 ± 1.1 | 1.5 ± 0.5 | 0.242 |
SOFA Sequential Organ Failure Assessment, APACHE Acute Physiology and Chronic Health Evaluation. Data are expressed as mean ± standard deviation
Clinical outcomes vs ultrasound profiles
Table 5 shows the risk for IDH, early interruption of intermittent hemodialysis, and 28-day mortality. Patients in profile D appeared to have a lower risk for all outcomes. There was an increased risk of IDH, dialysis discontinuation, and 28-day mortality in patients with profiles B and C.
Table 5.
Ultrasound profiles vs outcomes
| Profile | Parameter estimated | Standard error | Odds ratio | 95% CI | p | |
|---|---|---|---|---|---|---|
| Hypotension | ||||||
| A | − 2.530 | 0.404 | 0.08 | 0.036 | 0.176 | 0.001 |
| B | 2.511 | 0.430 | 12.321 | 5.304 | 28.624 | 0.001 |
| C | 2.811 | 0.476 | 16.633 | 6.544 | 42.277 | 0.001 |
| D | − 1.093 | 0.364 | 0.335 | 0.164 | 0.684 | 0.003 |
| Dialysis discontinuation | ||||||
| A | − 2.608 | 1.039 | 0.074 | 0.010 | 0.565 | 0.012 |
| B | 4.516 | 0.526 | 4.516 | 1.601 | 12.743 | 0.004 |
| C | 1.863 | 0.526 | 6.444 | 2.298 | 18.071 | 0.001 |
| D | − 1.835 | 1.041 | 0.160 | 0.021 | 1.228 | 0.780 |
| Mortality 28 days | ||||||
| A | − 1.072 | 0.360 | 0.342 | 0.169 | 0.694 | 0.003 |
| B | 0.580 | 0.399 | 1.786 | 0.817 | 3.907 | 0.146 |
| C | 1.284 | 0.385 | 3.612 | 1.697 | 7.688 | 0.001 |
| D | − 0.172 | 0.368 | 0.842 | 0.410 | 1.731 | 0.640 |
Discussion
In this study, we describe four clinical profiles based on ultrasound findings and their relation to IDH, interruption of dialysis, and overall mortality at 28 days. Patients with pulmonary congestion and hypervolemia (profile A) had a lower risk of IDH. In contrast, patients without pulmonary congestion and hypervolemia had the highest incidence of IDH. Sepsis, the use of norepinephrine, a low predialysis MAP, lactate level, and mechanical ventilation were significantly associated with IDH.
The pathogenesis of IDH includes the dialysis process itself and critically ill patient-related factors such as sepsis and sedation. Cardiac output and peripheral vasomotor tone are the main determinants of arterial pressure. In critically ill patients, dialysis hypotension is a result of the imbalance of these two variables [23]. Sepsis is the main etiology of AKI and causes a decrease in the peripheral vasomotor tone, induced by the release of vasodilating inflammatory mediators [24, 25]. During the ultrafiltration process, plasma volume decreases leading to an increase in protein level [26]. The resulting increase in oncotic pressure induces a water shift from interstitial and intracellular compartments toward intravascular compartment, which limits ultrafiltration-induced hypovolemia [27]. When ultrafiltration rate surpasses refilling rate, reduction in preload induces a fall in stroke volume that predisposes to hemodynamic instability [23, 27]. Normally, two physiological mechanisms are activated to maintain cardiac output and arterial pressure despite the reduction of stroke volume: an increase in heart rate and an increase in systemic vascular resistance. The dialysis process, however, interferes with this compensatory process [28]. Several mechanisms have been incriminated [27]: diffusion-induced changes in osmolality impairing baroreceptor activation, dialysis of plasma norepinephrine, calcium dialysate concentrations, and dialysate temperature. The hemodynamic impact of ultrafiltration is higher in critically ill patients with preload dependence and altered vasomotor tone [29].
Application of ultrasound has improved the care of critically ill patients with kidney diseases by providing an accurate estimation of volume status [14, 15] and pulmonary congestion [22]. It is also an accurate monitoring of treatment efficiency: the rate of disappearance of B lines following hemodialysis correlates with ultrafiltration and dry weight [5, 8]. Ultrasound determination of IVC expiratory diameter and collapsibility combined with clinical parameters have been used to monitor volume unloading during hemodialysis [29–32]. In the present study, critically ill patients treated by norepinephrine without hypervolemia were at high risk of IDH. We identified two profiles based on lung and vascular ultrasound able to predict the risk of IDH and guide the type of dialysis session. Critically ill patients with VCDi ≤ 11.5 mm m−2, an ultrasound value ruling out hypervolemia, were at risk of IDH in the presence or absence of lung congestion. At the opposite, hypervolemia defined as a VCDi ≥ 11.5 mm m−2 was protective against IDH in the presence or absence of lung congestion.
Before starting intermittent hemodialysis, the identification of patients with cardiopulmonary profiles increasing the risk of intradialytic hypotension should incite the clinician to select an alternative dialysis technique. Implementation of practice guidelines for intermittent hemodialysis can lessen hemodynamic instability [2]. Continuous renal replacement therapies (CRRT) provide hemodynamic stability, but the continuous session lasting 24–96 h requires expertise, anticoagulation, and alarm vigilance [33]. Extended daily dialysis is associated with similar outcomes to CRRT; however, further high-quality randomized controlled trials are desirable [34]. A technique of dialysis personalized to the risk of intradialytic hypotension is of critical importance, since intradialytic hypotension can increase mortality [35]. Recently, it has been shown that a high ultrafiltration rate (> 25 ml/kg/day) over the period of RRT significantly reduces the risk of 1-year mortality in 1075 patients with AKI and fluid overload > 5% of body weight [36]. Interestingly, MAP was lower for duration of RRT and cumulative norepinephrine dose higher in patients treated with low or moderate ultrafiltration rate, suggesting that IDH increased the mortality risk. However, it was impossible to conclude whether tolerating intensive ultrafiltration is simply a marker of recovery or a mediator [37]. Our results are similar: it is likely that the increased 28-day mortality observed in the 79 critically ill patients who experienced intradialytic hypotension was partly due to the hypotensive episodes, but the finding of increased mortality in patients with dialytic hypotension does not necessarily mean that hypotension causes mortality.
Our study has some limitations. It is a single-center study, and our findings have to be reproduced and our hypothesis tested in multicenter randomized controlled trials. We have only performed ultrasound studies just before hemodialysis initiation. The vena cava collapsibility was assessed either in patients with or without mechanical ventilation. The patients on mechanical ventilation, however, were lightly sedated and partly spontaneous breathing.
Conclusion
In critically ill patients with objective indications of emergent initiation of hemodialysis, the absence of hypervolemia with or without pulmonary congestion as assessed by vena cava and lung ultrasound predisposes to intradialytic hypotension. Further studies should be considered to validate these results and personalize the techniques of dialysis according to the risk of intradialytic hypotension.
Supplementary information
Additional file 1. Profile A. Patient with B lines > 14 and VCDi > 11.5 mm.m− 2.
Additional file 2. Patient with B lines < 14 and VCDi ≤11.5 mm.m− 2.
Additional file 3. Patient with B lines > 14 and VCDi ≤11.5 mm.m− 2.
Additional file 4. Patient with B lines < 14 and VCDi > 11.5 mm.m− 2.
Additional file 5. Ultrasound procedures and classifications
Acknowledgements
The authors are grateful to the Nephrology Team of the Hospital Português (Dr Andrea Pedroza, Dr. Fabio Dutra, Dr. Margarida Dutra, Dr. Luis Conceição, Dra Eva Miranda, Dr. Evandro Mendonça, and Dra. Fernanda Oliveira Coelho, Carolina Sá Nascimento).
Abbreviations
- IDH
Intradialytic hypotension
- ICU
Intensive care unit
- AKI
Acute kidney injury
- MAP
Mean arterial pressure
- IVC
Inferior vena cava
- IVCmax
Maximal IVC diameter
- IVCmin
Minimum IVC diameter
- IVCCI
IVC collapsibility index
- IQR
Interquartile range
- CRRT
Continuous renal replacement therapies
Authors’ contributions
RHP was responsible in the conception and design of the work, acquisition and interpretation of data, drafting the work, and performing ultrasound examinations. JCR was responsible in the interpretation of data and drafting the work. JGRR was responsible in the interpretation of data and drafting the work. EBSGM was responsible in the acquisition of data. MPDR was responsible in the acquisition of data and performing ultrasound examinations. MFCA was responsible in the acquisition of data and drafting the work. PBPB was responsible in the interpretation of data and drafting the work. OHCM was responsible in the acquisition of data. AMCF was responsible in the acquisition of data. EM was responsible in the interpretation of data and drafting the work. JJR was responsible in the interpretation of data and drafting the work. All authors read and approved the final manuscript.
Authors’ information
Not applicable
Funding
There was no funding source.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
The study was approved by the Ethical Committee from Centro de Estudos Egaz Muniz (CAAE: 89428318.000005029). Written informed consent was waived for this observational and non-interventional study.
Consent for publication
All authors reviewed the manuscript and consented to its publication.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary information accompanies this paper at 10.1186/s13054-019-2668-2.
References
- 1.Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17:109. doi: 10.1186/s12882-016-0323-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med. 2000;162:197–202. doi: 10.1164/ajrccm.162.1.9907098. [DOI] [PubMed] [Google Scholar]
- 3.Doshi M, Murray PT. Approach to intradialytic hypotension in intensive care unit patients with acute renal failure. Artif Organs. 2003;27:772–780. doi: 10.1046/j.1525-1594.2003.07291.x. [DOI] [PubMed] [Google Scholar]
- 4.Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, et al. The agreement between auscultation and lung ultrasound in hemodialysis patients: the LUST study. Clin J Am Soc Nephrol CJASN. 2016;11:2005–2011. doi: 10.2215/CJN.03890416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ross DW, Abbasi MM, Jhaveri KD, Sachdeva M, Miller I, Barnett R, et al. Lung ultrasonography in end-stage renal disease: moving from evidence to practice-a narrative review. Clin Kidney J. 2018;11:172–178. doi: 10.1093/ckj/sfx107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zoccali C, Torino C, Tripepi R, Tripepi G, D’Arrigo G, Postorino M, et al. Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol JASN. 2013;24:639–646. doi: 10.1681/ASN.2012100990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, et al. Detection of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc Imaging. 2010;3:586–594. doi: 10.1016/j.jcmg.2010.02.005. [DOI] [PubMed] [Google Scholar]
- 8.Noble VE, Murray AF, Capp R, Sylvia-Reardon MH, Steele DJR, Liteplo A. Ultrasound assessment for extravascular lung water in patients undergoing hemodialysis. Time course for resolution. Chest. 2009;135:1433–1439. doi: 10.1378/chest.08-1811. [DOI] [PubMed] [Google Scholar]
- 9.Douvris Adrianna, Zeid Khalid, Hiremath Swapnil, Bagshaw Sean M., Wald Ron, Beaubien-Souligny William, Kong Jennifer, Ronco Claudio, Clark Edward G. Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Medicine. 2019;45(10):1333–1346. doi: 10.1007/s00134-019-05707-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Monnet X, Cipriani F, Camous L, Sentenac P, Dres M, Krastinova E, et al. The passive leg raising test to guide fluid removal in critically ill patients. Ann Intensive Care. 2016;6:46. doi: 10.1186/s13613-016-0149-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bitker L, Bayle F, Yonis H, Gobert F, Leray V, Taponnier R, et al. Prevalence and risk factors of hypotension associated with preload-dependence during intermittent hemodialysis in critically ill patients. Crit Care. 2016;20:44. doi: 10.1186/s13054-016-1227-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.O’Connor ME, Jones SL, Glassford NJ, Bellomo R, Prowle JR. Defining fluid removal in the intensive care unit: a national and international survey of critical care practice. J Intensive Care Soc. 2017;18:282–288. doi: 10.1177/1751143717699423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.van der Sande FM, Dekker MJ, Leunissen KML, Kooman JP. Novel insights into the pathogenesis and prevention of intradialytic hypotension. Blood Purif. 2018;45:230–235. doi: 10.1159/000485160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kalantari K, Chang JN, Ronco C, Rosner MH. Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int. 2013;83:1017–1028. doi: 10.1038/ki.2012.424. [DOI] [PubMed] [Google Scholar]
- 15.Niyyar VD, O’Neill WC. Point-of-care ultrasound in the practice of nephrology. Kidney Int. 2018;93:1052–1059. doi: 10.1016/j.kint.2017.11.032. [DOI] [PubMed] [Google Scholar]
- 16.Krause I, Birk E, Davidovits M, Cleper R, Blieden L, Pinhas L, et al. Inferior vena cava diameter: a useful method for estimation of fluid status in children on haemodialysis. Nephrol Dial Transplant. 2001;16:1203–1206. doi: 10.1093/ndt/16.6.1203. [DOI] [PubMed] [Google Scholar]
- 17.Kaptein MJ, Kaptein JS, Oo Z, Kaptein EM. Relationship of inferior vena cava collapsibility to ultrafiltration volume achieved in critically ill hemodialysis patients. Int J Nephrol Renov Dis. 2018;11:195–209. doi: 10.2147/IJNRD.S165744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Clerico A, Vittorini S, Passino C. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. Clin Chem Lab Med. 2011;49:1949–1954. doi: 10.1515/CCLM.2011.686. [DOI] [PubMed] [Google Scholar]
- 19.Samoni S, Vigo V, Reséndiz LIB, Villa G, De Rosa S, Nalesso F, et al. Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording. Crit Care. 2016;20:95. doi: 10.1186/s13054-016-1269-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Cheriex EC, Leunissen KM, Janssen JH, Mooy JM, van Hooff JP. Echography of the inferior vena cava is a simple and reliable tool for estimation of “dry weight” in haemodialysis patients. Nephrol Dial Transplant. 1989;4:563–568. [PubMed] [Google Scholar]
- 21.Muniz Pazeli J, Fagundes Vidigal D, Cestari Grossi T, Silva Fernandes NM, Colugnati F, Baumgratz de Paula R, et al. Can nephrologists use ultrasound to evaluate the inferior vena cava? A cross-sectional study of the agreement between a nephrologist and a cardiologist. Nephron Extra. 2014;4:82–88. doi: 10.1159/000362170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Gargani L. Lung ultrasound: a new tool for the cardiologist. Cardiovasc Ultrasound. 2011;9:6. doi: 10.1186/1476-7120-9-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Schortgen F. Hypotension during intermittent hemodialysis: new insights into an old problem. Intensive Care Med. 2003;29:1645–1649. doi: 10.1007/s00134-003-1945-2. [DOI] [PubMed] [Google Scholar]
- 24.Monge García MI, Guijo González P, Gracia Romero M, Gil Cano A, Oscier C, Rhodes A, et al. Effects of fluid administration on arterial load in septic shock patients. Intensive Care Med. 2015;41:1247–1255. doi: 10.1007/s00134-015-3898-7. [DOI] [PubMed] [Google Scholar]
- 25.Ait-Oufella H, Maury E, Lehoux S, Guidet B, Offenstadt G. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med. 2010;36:1286–1298. doi: 10.1007/s00134-010-1893-6. [DOI] [PubMed] [Google Scholar]
- 26.Pietribiasi M, Katzarski K, Galach M, Stachowska-Piętka J, Schneditz D, Lindholm B, et al. Kinetics of plasma refilling during hemodialysis sessions with different initial fluid status. ASAIO J Am Soc Artif Intern Organs. 2015;61:350–356. doi: 10.1097/MAT.0000000000000206. [DOI] [PubMed] [Google Scholar]
- 27.Rouby JJ, Rottembourg J, Durande JP, Basset JY, Legrain M. Importance of the plasma refilling rate in the genesis of hypovolaemic hypotension during regular dialysis and controlled sequential ultrafiltration-haemodialysis. Proc Eur Dial Transpl. 1978;15:239–244. [PubMed] [Google Scholar]
- 28.Rouby JJ, Rottembourg J, Durande J-P, Basset J-Y, Degoulet P, Glaser P, et al. Hemodynamic changes induced by regular hemodialysis and sequential ultrafiltration hemodialysis: a comparative study. Kidney Int. 1980;17:801–810. doi: 10.1038/ki.1980.92. [DOI] [PubMed] [Google Scholar]
- 29.Ronco C, Ricci Z. Renal replacement therapies: physiological review. Intensive Care Med. 2008;34:2139–2146. doi: 10.1007/s00134-008-1258-6. [DOI] [PubMed] [Google Scholar]
- 30.Tetsuka T, Ando Y, Ono S, Asano Y. Change in inferior vena caval diameter detected by ultrasonography during and after hemodialysis. ASAIO J Am Soc Artif Intern Organs. 1995;41:105–110. [PubMed] [Google Scholar]
- 31.Brennan JM, Ronan A, Goonewardena S, Blair JEA, Hammes M, Shah D, et al. Handcarried ultrasound measurement of the inferior vena cava for assessment of intravascular volume status in the outpatient hemodialysis clinic. Clin J Am Soc Nephrol CJASN. 2006;1:749–753. doi: 10.2215/CJN.00310106. [DOI] [PubMed] [Google Scholar]
- 32.Guiotto G, Masarone M, Paladino F, Ruggiero E, Scott S, Verde S, et al. Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study. Intensive Care Med. 2010;36:692–696. doi: 10.1007/s00134-009-1745-4. [DOI] [PubMed] [Google Scholar]
- 33.Wehle B, Asaba H, Castenfors J, Fürst P, Gunnarsson B, Shaldon S, et al. Hemodynamic changes during sequential ultrafiltration and dialysis. Kidney Int. 1979;15:411–418. doi: 10.1038/ki.1979.53. [DOI] [PubMed] [Google Scholar]
- 34.Villa G, Neri M, Bellomo R, Cerda J, De Gaudio AR, De Rosa S, et al. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications. Crit Care. 2016;20:283. doi: 10.1186/s13054-016-1456-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol JASN. 2015;26:724–734. doi: 10.1681/ASN.2014020222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Murugan R, Kerti SJ, Chang C-CH, Gallagher M, Clermont G, Palevsky PM, et al. Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open. 2019;2:e195418. doi: 10.1001/jamanetworkopen.2019.5418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Murugan R, Balakumar V, Kerti SJ, Priyanka P, Chang C-CH, Clermont G, et al. Net ultrafiltration intensity and mortality in critically ill patients with fluid overload. Crit Care. 2018;22:223. doi: 10.1186/s13054-018-2163-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Additional file 1. Profile A. Patient with B lines > 14 and VCDi > 11.5 mm.m− 2.
Additional file 2. Patient with B lines < 14 and VCDi ≤11.5 mm.m− 2.
Additional file 3. Patient with B lines > 14 and VCDi ≤11.5 mm.m− 2.
Additional file 4. Patient with B lines < 14 and VCDi > 11.5 mm.m− 2.
Additional file 5. Ultrasound procedures and classifications
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.